Lab One Metropolis Healthcare Services Profile
Key Indicators
- Authorised Capital ₹ 1.33 Cr
as on 25-04-2024
- Paid Up Capital ₹ 1.33 Cr
as on 25-04-2024
- Company Age 12 Year, 1 Month
- Last Filing with ROC 31 Mar 2021
- Revenue -24.20%
(FY 2021)
- Profit -93.09%
(FY 2021)
- Ebitda -86.34%
(FY 2021)
- Net Worth 1.94%
(FY 2021)
- Total Assets 16.40%
(FY 2021)
About Lab One Metropolis Healthcare Services
- CIN/LLPIN
U93030MH2012PTC237337
- Company No.
237337
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Oct 2012
- Date of AGM
10 Aug 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
Who are the key members and board of directors at Lab One Metropolis Healthcare Services?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nilesh Shah  | Director | 31-Oct-2012 | Current |
| Vijender Singh | Director | 16-Aug-2016 | Current |
| Rakesh Agarwal | Director | 18-Nov-2019 | Current |
Financial Performance of Lab One Metropolis Healthcare Services.
Lab One Metropolis Healthcare Services Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 24.2% decrease. The company also saw a substantial fall in profitability, with a 93.09% decrease in profit. The company's net worth moved up by a moderate rise of 1.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lab One Metropolis Healthcare Services?
In 2021, Lab One Metropolis Healthcare Services had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Centre For Digestive And Kidney Diseases (India) Private LimitedActive 20 years 7 monthsRakesh Agarwal is a mutual person
Centralab Healthcare Services Private LimitedActive 13 years 8 monthsRakesh Agarwal is a mutual person
Ekopath Metropolis Lab Services Private LimitedActive 11 years 10 monthsNilesh Shah and Rakesh Agarwal are mutual person
Amin's Pathology Laboratory Private LimitedActive 12 years 2 monthsNilesh Shah and Rakesh Agarwal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Lab One Metropolis Healthcare Services?
Lab One Metropolis Healthcare Services has a workforce of 40 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lab One Metropolis Healthcare Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lab One Metropolis Healthcare Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
